What Are Anti-VEGF Therapies and Where Are They Used?

Anti-VEGF (vascular endothelial growth factor) therapies inhibit abnormal blood vessel growth. They are primarily used in treating eye disorders such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.

By blocking VEGF, these therapies reduce fluid leakage and prevent vision loss. Anti-VEGF drugs are administered through intravitreal injections and have significantly improved visual outcomes.

Beyond ophthalmology, anti-VEGF therapies are also used in oncology to inhibit tumor angiogenesis. Continuous research is improving drug efficacy and reducing treatment frequency.

With increasing prevalence of diabetes and aging populations, demand for anti-VEGF treatments continues to rise globally.